Samuel Urrutia-Argueta

9PUBLICATIONS
29CO-AUTHORS
Predictive and prognostic markersRespiratory diseasesInstrumental methods (excl. immunological and bioassay methods)Gene and molecular therapyMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 31, 2025
Decitabine-cedazuridine in patients with MDS and TP53 mutations.

Samuel Urrutia, Koji Sasaki, Alex Bataller

|Aug 19, 2025
Mortality and relapse dynamics in AML after three years of complete remission.

Samuel Urrutia, Wei-Ying Jen, Koji Sasaki

|Jul 29, 2025
A clinical guide to TP53 mutations in myeloid neoplasms.

Samuel Urrutia, Terrence N Wong, Daniel C Link

|Feb 21, 2025
Cytogenetic annotation automation in myelodysplastic syndrome research databases.

Samuel Urrutia, Kelly S Chien, Ziyi Li

|Feb 01, 2024
Cytogenetic and Molecular Associations with Outcomes in Higher-Risk Myelodysplastic Syndromes Treated with Hypomethylating Agents plus Venetoclax.

Alexandre Bazinet, Sai Prasad Desikan, Ziyi Li

|Jul 29, 2023
Performance of IPSS-M in patients with myelodysplastic syndrome after hypomethylating agent failure.

Samuel Urrutia, Kelly S Chien, Ziyi Li

Pageof 2

Frequent Collaborators

4 joint publications

Koji Sasaki

3 joint publications

Kelly S Chien

3 joint publications

Guillermo Montalban-Bravo

2 joint publications

Hagop Kantarjian